ICON PLC (ICLR) Stock Fundamental Analysis

NASDAQ:ICLR • IE0005711209

99.7 USD
+1.29 (+1.31%)
At close: Feb 20, 2026
99.7 USD
0 (0%)
After Hours: 2/20/2026, 8:00:01 PM
Overview Stock Chart Technical Analysis Fundamental Analysis Analyst Ratings Earnings Estimates Financials Ownership News
Fundamental Rating

5

Taking everything into account, ICLR scores 5 out of 10 in our fundamental rating. ICLR was compared to 58 industry peers in the Life Sciences Tools & Services industry. Both the profitability and the financial health of ICLR get a neutral evaluation. Nothing too spectacular is happening here. ICLR is valued quite cheap, while showing a decent growth score. This is a good combination!


Dividend Valuation Growth Profitability Health

6

1. Profitability

1.1 Basic Checks

  • In the past year ICLR was profitable.
  • In the past year ICLR had a positive cash flow from operations.
  • ICLR had positive earnings in each of the past 5 years.
  • Each year in the past 5 years ICLR had a positive operating cash flow.
ICLR Yearly Net Income VS EBIT VS OCF VS FCFICLR Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M 1B

1.2 Ratios

  • Looking at the Return On Assets, with a value of 3.63%, ICLR is in the better half of the industry, outperforming 75.86% of the companies in the same industry.
  • ICLR's Return On Equity of 6.42% is fine compared to the rest of the industry. ICLR outperforms 75.86% of its industry peers.
  • ICLR has a Return On Invested Capital of 6.74%. This is in the better half of the industry: ICLR outperforms 77.59% of its industry peers.
  • The Average Return On Invested Capital over the past 3 years for ICLR is significantly below the industry average of 12.04%.
  • The 3 year average ROIC (5.80%) for ICLR is below the current ROIC(6.74%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA 3.63%
ROE 6.42%
ROIC 6.74%
ROA(3y)3.74%
ROA(5y)4.36%
ROE(3y)6.96%
ROE(5y)8.15%
ROIC(3y)5.8%
ROIC(5y)6.92%
ICLR Yearly ROA, ROE, ROICICLR Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 5 10 15 20 25

1.3 Margins

  • ICLR has a better Profit Margin (7.40%) than 75.86% of its industry peers.
  • ICLR's Profit Margin has declined in the last couple of years.
  • ICLR has a better Operating Margin (13.99%) than 74.14% of its industry peers.
  • In the last couple of years the Operating Margin of ICLR has remained more or less at the same level.
  • ICLR has a worse Gross Margin (28.15%) than 77.59% of its industry peers.
  • In the last couple of years the Gross Margin of ICLR has remained more or less at the same level.
Industry RankSector Rank
OM 13.99%
PM (TTM) 7.4%
GM 28.15%
OM growth 3Y9.91%
OM growth 5Y-0.95%
PM growth 3Y50.65%
PM growth 5Y-6.44%
GM growth 3Y2.3%
GM growth 5Y-0.09%
ICLR Yearly Profit, Operating, Gross MarginsICLR Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 10 20 30 40

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

4

2. Health

2.1 Basic Checks

  • The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so ICLR is destroying value.
  • Compared to 1 year ago, ICLR has less shares outstanding
  • ICLR has more shares outstanding than it did 5 years ago.
  • The debt/assets ratio for ICLR has been reduced compared to a year ago.
ICLR Yearly Shares OutstandingICLR Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M
ICLR Yearly Total Debt VS Total AssetsICLR Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 5B 10B 15B

2.2 Solvency

  • ICLR has an Altman-Z score of 1.56. This is a bad value and indicates that ICLR is not financially healthy and even has some risk of bankruptcy.
  • ICLR has a Altman-Z score of 1.56. This is comparable to the rest of the industry: ICLR outperforms 55.17% of its industry peers.
  • The Debt to FCF ratio of ICLR is 3.53, which is a good value as it means it would take ICLR, 3.53 years of fcf income to pay off all of its debts.
  • ICLR's Debt to FCF ratio of 3.53 is fine compared to the rest of the industry. ICLR outperforms 79.31% of its industry peers.
  • A Debt/Equity ratio of 0.31 indicates that ICLR is not too dependend on debt financing.
  • ICLR has a Debt to Equity ratio (0.31) which is comparable to the rest of the industry.
Industry RankSector Rank
Debt/Equity 0.31
Debt/FCF 3.53
Altman-Z 1.56
ROIC/WACC0.78
WACC8.69%
ICLR Yearly LT Debt VS Equity VS FCFICLR Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B 8B

2.3 Liquidity

  • ICLR has a Current Ratio of 1.06. This is a normal value and indicates that ICLR is financially healthy and should not expect problems in meeting its short term obligations.
  • ICLR has a Current ratio of 1.06. This is amonst the worse of the industry: ICLR underperforms 82.76% of its industry peers.
  • ICLR has a Quick Ratio of 1.06. This is a normal value and indicates that ICLR is financially healthy and should not expect problems in meeting its short term obligations.
  • ICLR has a worse Quick ratio (1.06) than 77.59% of its industry peers.
Industry RankSector Rank
Current Ratio 1.06
Quick Ratio 1.06
ICLR Yearly Current Assets VS Current LiabilitesICLR Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

4

3. Growth

3.1 Past

  • ICLR shows a slight negative growth in Earnings Per Share. In the last year, the EPS has decreased by -5.99%.
  • Measured over the past years, ICLR shows a quite strong growth in Earnings Per Share. The EPS has been growing by 15.23% on average per year.
  • Looking at the last year, ICLR shows a decrease in Revenue. The Revenue has decreased by -2.46% in the last year.
  • Measured over the past years, ICLR shows a very strong growth in Revenue. The Revenue has been growing by 24.17% on average per year.
EPS 1Y (TTM)-5.99%
EPS 3Y13.76%
EPS 5Y15.23%
EPS Q2Q%-1.19%
Revenue 1Y (TTM)-2.46%
Revenue growth 3Y14.75%
Revenue growth 5Y24.17%
Sales Q2Q%0.63%

3.2 Future

  • Based on estimates for the next years, ICLR will show a small growth in Earnings Per Share. The EPS will grow by 5.45% on average per year.
  • Based on estimates for the next years, ICLR will show a small growth in Revenue. The Revenue will grow by 2.44% on average per year.
EPS Next Y-4.71%
EPS Next 2Y-1.84%
EPS Next 3Y2.13%
EPS Next 5Y5.45%
Revenue Next Year-2.43%
Revenue Next 2Y-1.11%
Revenue Next 3Y0.75%
Revenue Next 5Y2.44%

3.3 Evolution

  • The EPS growth rate is decreasing: in the next years the growth will be less than in the last years.
  • The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
ICLR Yearly Revenue VS EstimatesICLR Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 2B 4B 6B 8B 10B
ICLR Yearly EPS VS EstimatesICLR Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 10 20 30

More info and screens

Find the best growth stocksShow best growing peers

8

4. Valuation

4.1 Price/Earnings Ratio

  • The Price/Earnings ratio is 7.56, which indicates a rather cheap valuation of ICLR.
  • ICLR's Price/Earnings ratio is rather cheap when compared to the industry. ICLR is cheaper than 98.28% of the companies in the same industry.
  • The average S&P500 Price/Earnings ratio is at 26.99. ICLR is valued rather cheaply when compared to this.
  • A Price/Forward Earnings ratio of 7.39 indicates a rather cheap valuation of ICLR.
  • ICLR's Price/Forward Earnings ratio is rather cheap when compared to the industry. ICLR is cheaper than 98.28% of the companies in the same industry.
  • The average S&P500 Price/Forward Earnings ratio is at 28.06. ICLR is valued rather cheaply when compared to this.
Industry RankSector Rank
PE 7.56
Fwd PE 7.39
ICLR Price Earnings VS Forward Price EarningsICLR Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

  • Based on the Enterprise Value to EBITDA ratio, ICLR is valued cheaply inside the industry as 98.28% of the companies are valued more expensively.
  • Compared to the rest of the industry, the Price/Free Cash Flow ratio of ICLR indicates a rather cheap valuation: ICLR is cheaper than 98.28% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF 7.9
EV/EBITDA 6.87
ICLR Per share dataICLR EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 50 100

4.3 Compensation for Growth

  • The decent profitability rating of ICLR may justify a higher PE ratio.
PEG (NY)N/A
PEG (5Y)0.5
EPS Next 2Y-1.84%
EPS Next 3Y2.13%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. Dividend

5.1 Amount

  • ICLR does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

ICON PLC

NASDAQ:ICLR (2/20/2026, 8:00:01 PM)

After market: 99.7 0 (0%)

99.7

+1.29 (+1.31%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryLife Sciences Tools & Services
Earnings (Last)10-22
Earnings (Next)02-25
Inst Owners105.53%
Inst Owner Change5.2%
Ins Owners0.66%
Ins Owner ChangeN/A
Market Cap7.61B
Revenue(TTM)8.10B
Net Income(TTM)599.48M
Analysts74.17
Price Target209.67 (110.3%)
Short Float %3.73%
Short Ratio1.64
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-0.77%
Min EPS beat(2)-1.21%
Max EPS beat(2)-0.34%
EPS beat(4)1
Avg EPS beat(4)-0.63%
Min EPS beat(4)-1.21%
Max EPS beat(4)0.23%
EPS beat(8)1
Avg EPS beat(8)-2.34%
EPS beat(12)2
Avg EPS beat(12)-1.79%
EPS beat(16)5
Avg EPS beat(16)-1.4%
Revenue beat(2)1
Avg Revenue beat(2)0.4%
Min Revenue beat(2)-0.23%
Max Revenue beat(2)1.03%
Revenue beat(4)1
Avg Revenue beat(4)-0.84%
Min Revenue beat(4)-2.61%
Max Revenue beat(4)1.03%
Revenue beat(8)1
Avg Revenue beat(8)-2.24%
Revenue beat(12)1
Avg Revenue beat(12)-2.14%
Revenue beat(16)1
Avg Revenue beat(16)-2.06%
PT rev (1m)0%
PT rev (3m)-1.36%
EPS NQ rev (1m)0.02%
EPS NQ rev (3m)-0.03%
EPS NY rev (1m)-0.02%
EPS NY rev (3m)-0.04%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-0.05%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0.02%
Valuation
Industry RankSector Rank
PE 7.56
Fwd PE 7.39
P/S 0.94
P/FCF 7.9
P/OCF 6.68
P/B 0.82
P/tB N/A
EV/EBITDA 6.87
EPS(TTM)13.19
EY13.23%
EPS(NY)13.49
Fwd EY13.53%
FCF(TTM)12.63
FCFY12.66%
OCF(TTM)14.93
OCFY14.98%
SpS106.11
BVpS122.25
TBVpS-38.98
PEG (NY)N/A
PEG (5Y)0.5
Graham Number190.47
Profitability
Industry RankSector Rank
ROA 3.63%
ROE 6.42%
ROCE 8.53%
ROIC 6.74%
ROICexc 6.98%
ROICexgc 176.34%
OM 13.99%
PM (TTM) 7.4%
GM 28.15%
FCFM 11.9%
ROA(3y)3.74%
ROA(5y)4.36%
ROE(3y)6.96%
ROE(5y)8.15%
ROIC(3y)5.8%
ROIC(5y)6.92%
ROICexc(3y)5.97%
ROICexc(5y)8.67%
ROICexgc(3y)88.82%
ROICexgc(5y)90.84%
ROCE(3y)7.34%
ROCE(5y)8.76%
ROICexgc growth 3Y-4.45%
ROICexgc growth 5Y-5.01%
ROICexc growth 3Y27.99%
ROICexc growth 5Y-24.17%
OM growth 3Y9.91%
OM growth 5Y-0.95%
PM growth 3Y50.65%
PM growth 5Y-6.44%
GM growth 3Y2.3%
GM growth 5Y-0.09%
F-Score6
Asset Turnover0.49
Health
Industry RankSector Rank
Debt/Equity 0.31
Debt/FCF 3.53
Debt/EBITDA 1.89
Cap/Depr 45.31%
Cap/Sales 2.17%
Interest Coverage 250
Cash Conversion 74.92%
Profit Quality 160.84%
Current Ratio 1.06
Quick Ratio 1.06
Altman-Z 1.56
F-Score6
WACC8.69%
ROIC/WACC0.78
Cap/Depr(3y)27.79%
Cap/Depr(5y)38.09%
Cap/Sales(3y)1.87%
Cap/Sales(5y)1.83%
Profit Quality(3y)130.43%
Profit Quality(5y)205.36%
High Growth Momentum
Growth
EPS 1Y (TTM)-5.99%
EPS 3Y13.76%
EPS 5Y15.23%
EPS Q2Q%-1.19%
EPS Next Y-4.71%
EPS Next 2Y-1.84%
EPS Next 3Y2.13%
EPS Next 5Y5.45%
Revenue 1Y (TTM)-2.46%
Revenue growth 3Y14.75%
Revenue growth 5Y24.17%
Sales Q2Q%0.63%
Revenue Next Year-2.43%
Revenue Next 2Y-1.11%
Revenue Next 3Y0.75%
Revenue Next 5Y2.44%
EBIT growth 1Y-0.88%
EBIT growth 3Y26.12%
EBIT growth 5Y22.99%
EBIT Next Year1.2%
EBIT Next 3Y1.67%
EBIT Next 5Y3.12%
FCF growth 1Y86.71%
FCF growth 3Y15.01%
FCF growth 5Y25.32%
OCF growth 1Y72.39%
OCF growth 3Y15.78%
OCF growth 5Y25.55%

ICON PLC / ICLR FAQ

Can you provide the ChartMill fundamental rating for ICON PLC?

ChartMill assigns a fundamental rating of 5 / 10 to ICLR.


What is the valuation status for ICLR stock?

ChartMill assigns a valuation rating of 8 / 10 to ICON PLC (ICLR). This can be considered as Undervalued.


How profitable is ICON PLC (ICLR) stock?

ICON PLC (ICLR) has a profitability rating of 6 / 10.


What is the valuation of ICON PLC based on its PE and PB ratios?

The Price/Earnings (PE) ratio for ICON PLC (ICLR) is 7.56 and the Price/Book (PB) ratio is 0.82.


How financially healthy is ICON PLC?

The financial health rating of ICON PLC (ICLR) is 4 / 10.